Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 40,000 shares at $55.26 ($2.2M) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Scheduled sale ($2.2M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.26 | 17,217 | $951K | 42.9% |
| 2 | $55.26 | 17,217 | $951K | 42.9% |
| 3 | $56.20 | 2,783 | $156K | 7.1% |
| 4 | $56.20 | 2,783 | $156K | 7.1% |
| Total | $55.39 avg | 40,000 | $2.2M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-30 | $2.9M | — | Filing → |